The COVID pandemic has galvanised interest in the life sciences sector among investors. The UK Bioindustry Association (BIA) recently published a report on UK biotech financing for 2021, which shows that a record £4.5bn was invested into UK life sciences companies in 2021.
During this session our team of sector experts will cover:• IPO process• Specific DD requirements for life sciences companies• Role of a nomad• Preparing for an IPO• The investor ecosystem Date: Friday 25th March 2022 Time: 9:30am-10:30am
Click here to register your place
Speakers
Claus Andersen - Funding/Investment Partner, Corporate - Freeths Colin Aaronson - Director, Corporate Finance - Healthcare - Grant Thornton Vadim Alexandre - Head of Healthcare - SP Angel Corporate Finance Tim Davies - Regional Head, UK Primary Markets - The London Stock Exchange Plc
The content of this page is a summary of the law in force at the date of publication and is not exhaustive, nor does it contain definitive advice. Specialist legal advice should be sought in relation to any queries that may arise.
Contact us today
Whatever your legal needs, our wide ranging expertise is here to support you and your business, so let’s start your legal journey today and get you in touch with the right lawyer to get you started.
Get in touch
For general enquiries, please complete this form and we will direct your message to the most appropriate person.